Targeting tumor cells with bispecific antibodies and T cells

Journal of Controlled Release

Volumn 53, Issue 1-3, 1998, Pages 77-84

  Kranz, D M ^a   Manning, T C ^a   Rund, L A ^a   Cho, B K ^a   Gruber, M M ^a   Roy, E J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Bispecific Antibodies; Cytotoxic T Lymphocytes; Folate Receptor; Transgenic Mice

Indexed keywords

ANTIBODY CONJUGATE; BISPECIFIC ANTIBODY; FOLIC ACID; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; CANCER GRAFT; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; GRAFT REJECTION; IMMUNE DEFICIENCY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BISPECIFIC; DISEASE MODELS, ANIMAL; GENES, T-CELL RECEPTOR ALPHA; GENES, T-CELL RECEPTOR BETA; HUMANS; IMMUNOTHERAPY; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032580490     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00239-3     Document Type: Conference Paper

References (19)

1. Fanger M.W., Morganelli P.M., Guyre P.M. Bispecific antibodies. Crit. Rev. Immunol. 12:1992;101-124.
2. Bluestone J.A. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 2:1995;555.
3. Ross J.F., Chaudhuri P.K., Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines -Physiologic and clinical implications. Cancer. 73(9):1994;2432-2443.
4. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski V.R. Jr., Kamen B.A. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52(12):1992;3396-3401.
5. Sha W.C., Nelson C.A., Newberry R.D., Kranz D.M., Russell J.H., Loh D.Y. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature. 335:1988;271-274.
6. Sha W.C., Nelson C.A., Newberry R.D., Kranz D.M., Russell J.H., Loh D.Y. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature. 336:1988;73-76.
7. Mombaerts P., Iacomini J., Johnson R.S., Herrup K., Tonegawa S., Papaioannou V.E. RAG-1-Deficient Mice Have No Mature B and T Lymphocytes. Cell. 68:1992;869-877.
8. Kranz D.M., Tonegawa S., Eisen H.N. Attachment of an Anti-Receptor Antibody to Non-Target Cells Renders Them Susceptible to Lysis by a Clone of Cytotoxic T Lymphocytes. Proc. Natl. Acad. Sci. USA. 81:1984;7922-7926.
9. Brigle K.E., Westin E.H., Houghton M.T., Goldman I.D. Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement. J. Biol. Chem. 266(26):1991;17243-17249.
10. Brigle K.E., Spinella M.J., Westin E.H., Goldman I.D. Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells. Biochem. Pharmacol. 47(2):1994;337-345.
11. Leamon C.P., Low P.S. Selective targeting of malignant cells with cytotoxin-folate conjugates. J. Drug Target. 2(2):1994;101-112.
12. Roehm N.W., Carbone A., Kushnir E., Taylor B.A., Riblet R.J., Marrack P., Kappler J.W. The major histocompatibility complex-restricted antigen receptor on T cells: the genetics of expression of an allotype. J. Immunol. 135:1985;2176.
13. Cho B.K., Schodin B.A., Kranz D.M. Characterization of a single-chain antibody to the β-chain of the T cell receptor. J. Biol. Chem. 270:1995;25819-25826.
14. Leamon C.P., Low P.S. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. USA. A 88(13):1991;5572-5576.
15. Leamon C.P., Low P.S. Cytotoxicity of momordin-folate conjugates in cultured human cells. J. Biol. Chem. 267(35):1992;24966-24971.
16. Udaka K., Tsomides T.J., Eisen H.N. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell. 69:1992;989-998.
17. Udaka K., Wiesmuller K., Kienle S., Jung G., Walden P. Self-MHC-restricted peptides recognized by and alloreactive T-lymphocyte clone. J. Immunol. 157:1996;670-678.
18. Kranz D.M., Patrick T.A., Brigle K.E., Spinella M.J., Roy E.J. Conjugates of folate and anti-T cell receptor antibodies specifically target folate-receptor-positive tumor cells for lysis. Proc. Natl. Acad. Sci. USA. 92:1995;9057-9061.
19. Cho B.K., Roy E.J., Patrick T.A., Kranz D.M. Efficient CTL Lysis of Folate-Receptor-Positive Tumor Cells Mediated by Single-Chain Fv/Folate Conjugates. Bioconjugate Chem. 8:1997;338-346.